Synopsis
Synopsis
0
EU WC
0
Australia
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Garamycin Solution
2. Gentimicin Sulfate Solution
3. Gentamicin Sulfate, 500x Solution
4. Akos015895526
5. G0383
| Molecular Weight | 575.7 g/mol |
|---|---|
| Molecular Formula | C21H45N5O11S |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 7 |
| Exact Mass | 575.28362844 g/mol |
| Monoisotopic Mass | 575.28362844 g/mol |
| Topological Polar Surface Area | 283 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 717 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 13 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Genoptic |
| PubMed Health | Gentamicin |
| Drug Classes | Antibacterial, Antibiotic |
| Active Ingredient | Gentamicin sulfate |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | eq 0.3% base |
| Market Status | Prescription |
| Company | Allergan |
| 2 of 2 | |
|---|---|
| Drug Name | Genoptic |
| PubMed Health | Gentamicin |
| Drug Classes | Antibacterial, Antibiotic |
| Active Ingredient | Gentamicin sulfate |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | eq 0.3% base |
| Market Status | Prescription |
| Company | Allergan |
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-08-14
Pay. Date : 2019-04-10
DMF Number : 30693
Submission : 2016-06-28
Status : Active
Type : II
NDC Package Code : 42513-0008
Start Marketing Date : 2014-09-22
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 6155
Submission : 2016-07-01
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13704
Submission : 1998-09-01
Status : Active
Type : II
Certificate Number : CEP 2005-121 - Rev 02
Issue Date : 2024-10-21
Type : Chemical
Substance Number : 331
Status : Valid
Registration Number : 220MF10041
Registrant's Address : Verovskova ulica 57, 1526 Ljubljana, Slovenia
Initial Date of Registration : 2008-02-05
Latest Date of Registration :
NDC Package Code : 48866-8256
Start Marketing Date : 2013-07-12
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24198
Submission : 2010-09-21
Status : Active
Type : II
NDC Package Code : 52946-0605
Start Marketing Date : 2010-04-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2013-09-21
Pay. Date : 2013-09-11
DMF Number : 12048
Submission : 1996-06-30
Status : Active
Type : II
Certificate Number : R1-CEP 1998-155 - Rev 10
Issue Date : 2019-02-18
Type : Chemical
Substance Number : 331
Status : Valid
Registration Number : 217MF10342
Registrant's Address : No. 6, Gaogang Avenue, Jiangyin Industrial Estate, Fuqing, Fuzhou, Fujian, China
Initial Date of Registration : 2005-07-27
Latest Date of Registration :
NDC Package Code : 67630-0003
Start Marketing Date : 2011-03-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13630
Submission : 1998-09-01
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14753
Submission : 1998-09-01
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13658
Submission : 1998-09-01
Status : Inactive
Type : II

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13625
Submission : 1998-09-01
Status : Inactive
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13671
Submission : 1998-09-01
Status : Inactive
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19916
Submission : 2006-08-31
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
12
PharmaCompass offers a list of Gentamicin Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Gentamicin Sulfate manufacturer or Gentamicin Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gentamicin Sulfate manufacturer or Gentamicin Sulfate supplier.
A Gentamcin Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gentamcin Sulfate, including repackagers and relabelers. The FDA regulates Gentamcin Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gentamcin Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gentamcin Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Gentamcin Sulfate supplier is an individual or a company that provides Gentamcin Sulfate active pharmaceutical ingredient (API) or Gentamcin Sulfate finished formulations upon request. The Gentamcin Sulfate suppliers may include Gentamcin Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Gentamcin Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Gentamcin Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Gentamcin Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Gentamcin Sulfate DMFs exist exist since differing nations have different regulations, such as Gentamcin Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Gentamcin Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Gentamcin Sulfate USDMF includes data on Gentamcin Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gentamcin Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Gentamcin Sulfate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Gentamcin Sulfate Drug Master File in Japan (Gentamcin Sulfate JDMF) empowers Gentamcin Sulfate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Gentamcin Sulfate JDMF during the approval evaluation for pharmaceutical products. At the time of Gentamcin Sulfate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Gentamcin Sulfate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Gentamcin Sulfate Drug Master File in Korea (Gentamcin Sulfate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Gentamcin Sulfate. The MFDS reviews the Gentamcin Sulfate KDMF as part of the drug registration process and uses the information provided in the Gentamcin Sulfate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Gentamcin Sulfate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Gentamcin Sulfate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Gentamcin Sulfate suppliers with KDMF on PharmaCompass.
A Gentamcin Sulfate CEP of the European Pharmacopoeia monograph is often referred to as a Gentamcin Sulfate Certificate of Suitability (COS). The purpose of a Gentamcin Sulfate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Gentamcin Sulfate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Gentamcin Sulfate to their clients by showing that a Gentamcin Sulfate CEP has been issued for it. The manufacturer submits a Gentamcin Sulfate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Gentamcin Sulfate CEP holder for the record. Additionally, the data presented in the Gentamcin Sulfate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Gentamcin Sulfate DMF.
A Gentamcin Sulfate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Gentamcin Sulfate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Gentamcin Sulfate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gentamcin Sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Gentamcin Sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Gentamcin Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Gentamcin Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gentamcin Sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Gentamcin Sulfate suppliers with NDC on PharmaCompass.
Gentamcin Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gentamcin Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Gentamcin Sulfate GMP manufacturer or Gentamcin Sulfate GMP API supplier for your needs.
A Gentamcin Sulfate CoA (Certificate of Analysis) is a formal document that attests to Gentamcin Sulfate's compliance with Gentamcin Sulfate specifications and serves as a tool for batch-level quality control.
Gentamcin Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Gentamcin Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gentamcin Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Gentamcin Sulfate EP), Gentamcin Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gentamcin Sulfate USP).